News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Investor's Business Daily60d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?Motley Fool61d agobullish
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right NowMarketWatch64d agobullish
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.Motley Fool64d agobullish
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King)24/7 Wall St.65d agoneutral
AbbVie’s Humira Cash Cow Is Shrinking - Can Its Dividend Keep Growing?BioPharma Dive65d agoneutral
Trailing rivals, AbbVie scores win with dual-acting myeloma drugBioPharma Dive65d agoneutral
This week in charts: China deals, stock flatlines and Lilly’s M&A spreeSimply Wall St.65d agoneutral
AbbVie (ABBV) Reports Positive Phase 3 Results For Etentamig In Multiple MyelomaInsider Monkey66d agoneutral
AbbVie (ABBV)’s Blood Cancer Success Adds Weight to its Pipeline StoryGuruFocus.com66d agoneutral
AbbVie's Etentamig Delivers 74% Response Rate in Pivotal Cancer TrialGuruFocus.com66d agobearish
The "Untouchable" List: Stocks That Short Sellers Won't Dare Bet Against